TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Biolabs AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
10,045
|
10,331
|
11,526 |
Financial expenses |
16
|
4
|
0 |
Earnings before taxes |
-259
|
-130
|
591 |
EBITDA |
-131
|
3
|
732 |
Total assets |
3,491
|
3,171
|
3,650 |
Current assets |
3,259
|
2,833
|
3,270 |
Current liabilities |
2,312
|
2,092
|
2,041 |
Equity capital |
1,173
|
1,015
|
1,507 |
- share capital |
216
![]() |
216
|
235 |
Employees (average) |
30
|
28
|
25 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.6%
|
32.0%
|
41.3% |
Turnover per employee |
335
|
369
|
461 |
Profit as a percentage of turnover |
-2.6%
|
-1.3%
|
5.1% |
Return on assets (ROA) |
-7.0%
|
-4.0%
|
16.2% |
Current ratio |
141.0%
|
135.4%
|
160.2% |
Return on equity (ROE) |
-22.1%
|
-12.8%
|
39.2% |
Change turnover |
-317
|
-261
|
-1,604 |
Change turnover % |
-3%
|
-2%
|
-12% |
Chg. No. of employees |
2
|
3
|
2 |
Chg. No. of employees % |
7%
|
12%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.